Yves Cariou, PharmD, MSc, is an independent strategy consultant focused on the market access of healthcare innovations and new therapies.
Yves retains a >15-year experience with the market access, pricing and reimbursement healthcare products and services. Yves brings a track record of more than 150 projects in various therapeutic areas related to healthcare innovations – orphan diseases, targeted and cancer therapies, medical devices and overall therapeutic answers to high unmet need diseases.
Yves has a broad understanding of the funding mechanisms supporting the diffusion of healthcare innovation across the inpatient, outpatient and the ambulatory settings of care. His in depth understanding of the EU 5 healthcare systems, supported by a network of strategic partners, allows him to develop tailored recommendation on how clinical evidence and value proposition should be framed to optimise pricing and funding. His key success factor remains his ability to focus a dedicated methodology on each of his client’s needs, in the field of clinical development, early access to innovation and premium price funding.
Yves has a PharmD, a MSc from HEC Paris, a master in therapeutic biotechnology and worked for multiple companies across the globe.
Attend Cannabis Europa London 2026
General Release
VIP Experience
BoC Awards
Working with Prohibition Partners for Cannabis Europa has been an absolute pleasure. Their dedication, exceptional professionalism, and collaborative spirit have made a meaningful difference, and we sincerely value their support.
We were truly honoured to sponsor the VIP Lounge and be part of an event that continues to set the standard for meaningful dialogue and progress in the medical cannabis industry. We left feeling excited and optimistic about the future.
